| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
| 08/13/2013 | US8507273 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 08/13/2013 | US8507249 Bacterial virulence factors and uses thereof |
| 08/13/2013 | US8507211 Tuberculosis diagnostic test |
| 08/13/2013 | US8507008 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
| 08/13/2013 | US8506994 Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 08/13/2013 | US8506960 Antibody molecule for human GM-CSF receptor alpha |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | US8506956 Method for stabilizing reduced coenzyme Q10 |
| 08/13/2013 | US8506949 Methods for modulating inflammatory and/or immune responses |
| 08/13/2013 | US8506944 Replenishment and enrichment of ocular surface lubrication |
| 08/13/2013 | CA2743539C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2743313C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2650478C Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 08/13/2013 | CA2567830C Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 08/13/2013 | CA2544473C A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2526891C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2517673C Improved vaccines for preventing viral infection |
| 08/13/2013 | CA2516777C Human cyclooxygenase-3 enzyme and uses thereof |
| 08/13/2013 | CA2488803C Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 08/13/2013 | CA2482930C Epha2 antigen t epitopes |
| 08/13/2013 | CA2469151C Immunocytokines with modulated selectivity |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/13/2013 | CA2314319C Novel surface protein of neisseria meningitidis |
| 08/13/2013 | CA2225377C Novel tgf-.beta. like cytokine |
| 08/08/2013 | WO2013116829A1 Novel engineered potent cytotoxic stapled bh3 peptides |
| 08/08/2013 | WO2013116781A1 Alk1 antagonists and their uses in treating renal cell carcinoma |
| 08/08/2013 | WO2013116744A1 Biomaterial for articular cartilage maintenance and treatment of arthritis |
| 08/08/2013 | WO2013116732A1 Enzyme compositions and use thereof for wound healing |
| 08/08/2013 | WO2013116645A1 Self-assembling molecules that accumulate in acidic tumor microenvironments |
| 08/08/2013 | WO2013116592A1 Once daily treatment of hepatitis c with ribavirin and taribavirin |
| 08/08/2013 | WO2013116590A1 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| 08/08/2013 | WO2013116541A1 Gamma interferon treated pluripotent germ layer origin antigen presenting cancer vaccine |
| 08/08/2013 | WO2013116482A1 Process of afod and afcc and manufacturing and purification processes of proteins |
| 08/08/2013 | WO2013116327A1 Methods and compositions for treatment of penile defects |
| 08/08/2013 | WO2013116312A1 ß-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 08/08/2013 | WO2013116307A1 Method for programming differentiated cells into hematopoietic stem cells |
| 08/08/2013 | WO2013116226A2 Prevention of mild cognitive impairment and eventual alzheimer's disease |
| 08/08/2013 | WO2013115926A2 Aspartyl-trna synthetase-fc conjugates |
| 08/08/2013 | WO2013114369A1 Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same |
| 08/08/2013 | WO2013114359A1 System and method for producing interleukin receptor antagonist (ira) |
| 08/08/2013 | WO2013113916A2 Ghrelin analogues |
| 08/08/2013 | WO2013113821A1 Device-based methods for localised delivery of cell-free carriers with stress-induced cellular factors |
| 08/08/2013 | WO2013113774A1 Factor xii inhibitors for the treatment of neurological inflammatory disorders |
| 08/08/2013 | WO2013113755A1 Reagents and methods for the treatment of diseases based on the inhibition of calcineurin - nfat signalling pathway |
| 08/08/2013 | WO2013113107A1 Methods for promoting neuron survival, axonal growth and/or regeneration |
| 08/08/2013 | WO2013113074A1 Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor |
| 08/08/2013 | WO2013113060A1 Peptide |
| 08/08/2013 | WO2013086052A3 Antibodies useful in passive influenza immunization |
| 08/08/2013 | WO2013073998A3 Novel derivatives of hemin with antibacterial and antiviral activity |
| 08/08/2013 | WO2013071038A3 Antagonists for abnormal vasopressin v2 receptor and uses thereof |
| 08/08/2013 | WO2013065017A3 Platelet rich plasma (prp) and prominin-1 derived peptides stimulate lymphangiogenesis |
| 08/08/2013 | WO2012175742A3 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203979 Use of lipid conjugates in the treatment of diseases |
| 08/08/2013 | US20130203977 Oligonucleotides comprising alternating segments and uses thereof |
| 08/08/2013 | US20130203961 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 08/08/2013 | US20130203840 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 08/08/2013 | US20130203839 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130203684 Method of achieving a thymosin beta 4 concentration in a human patient |
| 08/08/2013 | US20130203682 Rank ligand polypeptides |
| 08/08/2013 | US20130203681 Macrocyclic Compounds Useful as Inhibitors of Histone Deacetylases |
| 08/08/2013 | US20130203678 Compstatin analogs for treatment of neuropathic pain |
| 08/08/2013 | US20130203674 Process for production of bivalirudin |
| 08/08/2013 | US20130203673 Glucagon-like peptide-2 analogs |
| 08/08/2013 | US20130203671 Flibanserin for the Treatment of Urinary Incontinence and Related Diseases |
| 08/08/2013 | US20130203670 Therapy For Vitiligo |
| 08/08/2013 | US20130203669 Medicament |
| 08/08/2013 | US20130203668 Pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent |
| 08/08/2013 | US20130203667 Methods and Compositions for Promoting Organ Development |
| 08/08/2013 | US20130203666 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| 08/08/2013 | US20130203663 Tube feed formulations and methods for using same |
| 08/08/2013 | US20130203658 Low-Caloric High-Protein Nutritional Composition for the Stimulation of Muscle Protein Synthesis |
| 08/08/2013 | US20130203655 Methods for preventing or treating viral infection |
| 08/08/2013 | US20130203653 Bacterial-derived blis for treatment of acne |
| 08/08/2013 | US20130203651 Pharmaceutical composition for treating a metabolic syndrome |
| 08/08/2013 | US20130203646 Supporting activities of daily living |
| 08/08/2013 | US20130203645 Method of enhancing muscle protein synthesis |
| 08/08/2013 | US20130203169 Conditioned cell culture medium compositions and methods of use |
| 08/08/2013 | US20130202707 Controlled Delivery of TLR Agonists in Structural Polymeric Devices |
| 08/08/2013 | US20130202696 Agent for use in the case of fructose intolerance |
| 08/08/2013 | US20130202695 Agent for use in the case of fructose intolerance |
| 08/08/2013 | US20130202694 Agent for use in the case of fructose intolerance |
| 08/08/2013 | US20130202682 Synthetic matrix vesicles for biomimetic mineralization |
| 08/08/2013 | US20130202681 Liposomally encapsulated reduced glutathione for management of cancer and disruption of cancer energy cycles |
| 08/08/2013 | US20130202669 Albumin fibers and fabrics and methods of generating and using same |
| 08/08/2013 | US20130202614 Autotaxin pathway modulation and uses thereof |
| 08/08/2013 | US20130202613 Pharmacological vitreolysis |
| 08/08/2013 | US20130202612 Compositions and methods for treating bone conditions |
| 08/08/2013 | US20130202601 Assays, methods and kits for predicting renal disease and personalized treatment strategies |
| 08/08/2013 | US20130202595 Factor IX Polypeptides and Methods of Use Thereof |
| 08/08/2013 | US20130202594 ALK1 Antagonists and Their Uses in Treating Renal Cell Carcinoma |
| 08/08/2013 | US20130202583 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 08/08/2013 | US20130202581 Enzyme compositions and use thereof for wound healing |
| 08/08/2013 | US20130202578 Compositions and methods for selectively producing sirna |